Technology transfer within major pharma

The client was a major pharma that acquired outside technology targeted at an enterprise-critical production process. ZeeForge was retained to assess the applied functionality of the new technology, explore issues related to its use, and determine the best business alternatives for future support of the technology and process. After consultation with the client, ZeeForge was tasked to answer two questions: (1) How well is the new technology supporting the work of the critical process and (2) What, if anything, should be done to address any issues or pitfalls discovered about the performance and use of the technology?

ZeeForge is eager to share more information about this example. We are still preparing that information for publication. Please use the form below to request our pre-publication material.